Netarsudil dimesylate

Overview

Netarsudil (AR-13324) dimesylate is a competitive inhibitor of Rho-associated protein kinases ( ROCK I and ROCK II ) and a reversible inhibitor of the norepinephrine transporter ( NET ). Netarsudil dimesylate reduces intraocular pressure by inhibiting ROCK , causing relaxation of trabecular meshwork cells and dilation of episcleral veins, thereby increasing the ease of aqueous humor outflow, while inhibiting NET to reduce aqueous humor production. Netarsudil dimesylate is mainly used in the study of ocular hypertension and primary open-angle glaucoma.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Neurological Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > ROCK

Product Information

• Catalog No.: HY-12798A
• CAS No.: 1422144-42-0
• Molecular Formula: C30H35N3O9S2
• Molecular Weight: 645.74
• Purity: 99.90%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (3.87 mM); Clear solution
• Availability: In-stock

Source

Original product source